Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Synlogic Inc. (SYBX)

2.04   0 (0%) 07-07 15:38
Open: 2.03 Pre. Close: 2.04
High: 2.085 Low: 1.98
Volume: 117,904 Market Cap: 67M
Synlogic, Inc. a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its lead therapeutic programs include SYNB1020, an oral therapy for the treatment of hyperammonemia, which includes patients with liver diseases, such as hepatic encephalopathy, as well as patients with urea cycle disorders; and SYNB1618, an oral therapy that is in Phase I/IIa clinical trial to treat phenylketonuria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine to treat immuno-oncology solid tumors. It has collaboration agreements with AbbVie S..r.l. to develop synthetic biotic medicines for the treatment of inflammatory bowel diseases; and Ginkgo Bioworks to enable the discovery of new living medicines. The company also has a clinical collaboration with Hoffman-La Roche Ltd.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.061 - 2.071 2.071 - 2.081
Low: 1.947 - 1.957 1.957 - 1.967
Close: 2.023 - 2.04 2.04 - 2.057

Technical analysis

as of: 2020-07-07 3:39:05 PM
Stoxline posted a STRONG BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.74     One year: 3.06
Support: Support1: 1.91    Support2: 1.59
Resistance: Resistance1: 2.35    Resistance2: 2.62
Pivot: 2.08
Moving Average: MA(5): 2.01     MA(20): 2.11
MA(100): 2.11     MA(250): 2.71
MACD: MACD(12,26): -0.06     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 25.51     %D(3): 22.04
RSI: RSI(14): 45.46
52-week: High: 8.80  Low: 1.35  Change(%): -76.4
Average Vol(K): 3-Month: 34718  10-Days: 47050

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
SYBX has closed above bottom band by 41.5%. Bollinger Bands are 54.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to SYBX's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 15 Jun 2020
AstroNova, Inc. (ALOT): Hedge Funds In Wait-and-See Mode - Yahoo Finance

Fri, 12 Jun 2020
Is Synlogic, Inc. (SYBX) A Good Stock To Buy? - Yahoo Finance

Thu, 21 May 2020
Synlogic Announces Termination of AbbVie Collaboration Agreement - PRNewswire

Mon, 11 May 2020
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha

Mon, 04 May 2020
Synlogic Announces First Quarter 2020 Conference Call and Webcast - Yahoo Finance

Tue, 21 Apr 2020
How Many Synlogic, Inc. (NASDAQ:SYBX) Shares Do Institutions Own? - Simply Wall St

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33
Shares Float (M) 17
% Held by Insiders 21.44
% Held by Institutions 51.70
Shares Short (K) 503
Shares Short P. Month (K) 1,450

Stock Financials

EPS -1.668
EPS Est This Year -3.200
EPS Est Next Year -1.500
Book Value (p.s.) 4.380
Profit Margin
Operating Margin -2875.63
Return on Assets (ttm) -22.6
Return on Equity (ttm) -42.7
Qtrly Rev. Growth -70.4
Gross Profit (p.s.) 0.068
Sales Per Share 0.061
EBITDA (p.s.) -1.657
Qtrly Earnings Growth
Operating Cash Flow (M) -75
Levered Free Cash Flow (M) -43

Stock Valuations

PE Ratio -1.23
PEG Ratio
Price to Book value 0.47
Price to Sales 33.83
Price to Cash Flow -0.90

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.